Back to Search Start Over

The RESOLVE Trial for people with chronic low back pain: protocol for a randomised clinical trial

Authors :
Bagg, MK
Hübscher, M
Rabey, M
Wand, BM
O'Hagan, E
Moseley, GL
Stanton, TR
Maher, CG
Goodall, S
Saing, S
O'Connell, NE
Luomajoki, H
McAuley, JH
Bagg, MK
Hübscher, M
Rabey, M
Wand, BM
O'Hagan, E
Moseley, GL
Stanton, TR
Maher, CG
Goodall, S
Saing, S
O'Connell, NE
Luomajoki, H
McAuley, JH
Publication Year :
2017

Abstract

© 2016 Australian Physiotherapy Association Introduction Low back pain is the leading worldwide cause of disability, and results in significant personal hardship. Most available treatments, when tested in high-quality randomised, controlled trials, achieve only modest improvements in pain, at best. Recently, treatments that target central nervous system function have been developed and tested in small studies. Combining treatments that target central nervous system function with traditional treatments directed towards functioning of the back is a promising approach that has yet to be tested in adequately powered, prospectively registered, clinical trials. The RESOLVE trial will be the first high-quality assessment of two treatment programs that combine central nervous system-directed and traditional interventions in order to improve chronic low back pain. Aim To compare the effectiveness of two treatment programs that combine central nervous system-directed and traditional interventions at reducing pain intensity at 18 weeks post randomisation in a randomised clinical trial of people with chronic low back pain. Design Two-group, randomised, clinical trial with blinding of participants and assessors. Participants and setting Two hundred and seventy-five participants with chronic low back pain that has persisted longer than 3 months and no specific spinal pathology will be recruited from the community and primary care in Sydney, Australia. Interventions Both of the interventions contain treatments that target central nervous system function combined with treatments directed towards functioning of the back. Adherence to the intervention will be monitored using an individual treatment diary and adverse events recorded through passive capture. Participants are informed prior to providing informed consent that some of the treatments are not active. Blinding is maintained by not disclosing any further information. Complete disclosure of the contents of the intervention has

Details

Database :
OAIster
Publication Type :
Electronic Resource
Accession number :
edsoai.on1197486977
Document Type :
Electronic Resource